New antibiotic under watch: safety check after market launch
NCT ID NCT05733104
Summary
This study is monitoring the safety and real-world effectiveness of the antibiotic Zavicefta after its approval in Korea. It involves about 600 patients aged 3 months and older who are prescribed Zavicefta for serious infections like complicated abdominal infections, urinary tract infections, or hospital-acquired pneumonia. The goal is to identify any side effects and see how well the drug works in everyday medical practice, as required by Korean regulations.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMPLICATED INTRA-ABDOMINAL INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pfizer
RECRUITINGSeoul, Gangnam-gu, 06273, South Korea
Conditions
Explore the condition pages connected to this study.